Newsroom | 9474 results

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), een wereldwijd oncologiebedrijf, vernieuwt het behandelingsparadigma voor chronische lymfatische leukemie (CLL) tijdens de jaarlijkse bijeenkomst van de American Society of Clinical Oncology (ASCO) in 2026. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldi...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), un'azienda oncologica a livello globale, sta portando avanti il paradigma terapeutico nella leucemia linfatica cronica (LLC) al Meeting annuale 2026 dell'American Society of Clinical Oncology (ASCO). Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al tes...

SAN CARLOS, Califórnia--(BUSINESS WIRE)--A BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), uma empresa global de oncologia, está avançando o paradigma de tratamento da leucemia linfocítica crônica (LLC) na Reunião Anual da Sociedade Americana de Oncologia Clínica (ASCO) de 2026. Com um extenso acompanhamento de longo prazo, o estudo SEQUOIA com BRUKINSA® (zanubrutinibe) reforça seu papel como o inibidor fundamental da BTK, demonstrando controle sustentado da doença ao longo de ano...

WILMINGTON, Del.--(BUSINESS WIRE)--Residents of Delaware County will soon have a new option for around-the-clock emergency and inpatient care closer to home. In early June, ChristianaCare will open ChristianaCare Hospital, Aston, a neighborhood hospital designed to expand access to care in a growing region with increasing health care needs. Download photos. The hospital is expected to care for approximately 15,000 patients each year, or about 40 per day, and will provide 24/7 emergency care, in...

BORDEAUX, France--(BUSINESS WIRE)--HeartFocus, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, has announced its expansion to any cart-based system with the launch of HeartFocus Link. Available now for medical schools, residency, and ultrasound training programs, HeartFocus Link addresses one of the most persistent barriers in cardiac ultrasound education and adoption: the challenge of helping healthcare professionals build confidence and competency using the...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further suppo...

CLICHY, France--(BUSINESS WIRE)--CorWave, société pionnière dans le développement de dispositifs d’assistance cardiaque innovants, annonce la certification de son système de management de la qualité par un organisme notifié indépendant, conformément à la norme internationale ISO 13485. La certification obtenue couvre la conception et le développement, la fabrication, la distribution et le service-après-vente de dispositifs d’assistance ventriculaire gauche implantables (LVAD). L’entreprise fran...

CLICHY, France--(BUSINESS WIRE)--CorWave, a clinical-stage medical company pioneering innovative cardiac assist devices, announces that its Quality Management System has been certified by an independent notified body in accordance with the international ISO 13485 standard. The certification covers the design, development, manufacturing, distribution, and servicing of implantable Left Ventricular Assist Devices (LVADs). This certification marks a foundational regulatory milestone on the path to...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Palmetto GBA has issued a final Local Coverage Determination (LCD L40205) establishing Medicare coverage guidance for irreversible electroporation (IRE), the non-thermal ablation technology delivered by the Company's NanoKnife System, in...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Coredio, a digital health company developing the first software-as-a-medical-device (SaMD) platform dedicated to heart failure (HF) hemodynamic assessment, today announced that the U.S. Food and Drug Administration has granted its Cardiac Performance Simulation Engine (CPSE™) Breakthrough Device Designation and accepted the platform into the FDA’s Total Product Life Cycle Advisory Program (TAP). CPSE™ is a software-only platform designed to deliver catheter...